Marta Dragosky
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry.
Journal: American journal of hematology
Published: May 19, 2022
The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease.
Journal: American journal of hematology
Published: October 10, 2019
Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.
Journal: Blood cells, molecules & diseases
Published: April 05, 2019
Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial.
Journal: American journal of hematology
Published: July 20, 2018
Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.
Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.
Journal: Blood cells, molecules & diseases
Published: February 26, 2018
Evaluation of Bone Mineral Density in Patients with Type 1 Gaucher Disease in Argentina.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
Published: June 01, 2016
Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat.
Journal: Skeletal radiology
Published: March 27, 2014
Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment.
Journal: Blood cells, molecules & diseases
Published: March 03, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026